AVEO: More Open Questions Than Answers - Seeking Alpha PDF Print
Seeking Alpha
Earlier this week, AVEO (AVEO) announced topline results from a phase III trial for tivozanib in renal cancer. Although technically the trial met its primary endpoint and could probably lead to approval, results were far from satisfactory.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.